mr JAMES EDWARDS jr

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B (Docket No. CMS-2025-1889-0001) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D (Docket No. CMS-2025-1888-0001) Elimination of the Center for Medicare and Medicaid Innovation (CMMI) Approval of reauthorization of Floridas Medicaid hospital-directed payment program (DPP) S. 3315 (Health Care Cybersecurity & Resiliency Act) regarding Sen. Bernie Sanderss amendments to codify Most Favored Nation drug price controls

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

Independent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act) Guidance regarding Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles Phase 3 (GHG3) final rule and the Clean Trucks Plans 2022 Heavy-Duty Nitrous Oxide (NOx) EPAs rescinding the Obama endangerment finding that recategorized greenhouse gases as posing a threat to public health and welfare under the Clean Air Act

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 3244 (Capital Access for Small Businesses Harmonization (CASH) Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act) Guidance regarding Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles Phase 3 (GHG3) final rule and the Clean Trucks Plans 2022 Heavy-Duty Nitrous Oxide (NOx) EPAs rescinding the Obama endangerment finding that recategorized greenhouse gases as posing a threat to public health and welfare under the Clean Air Act

H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act) S. 527 (Prescription Pricing for the People Act) Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

Executive Order 14192, Unleashing Prosperity Through Deregulation H. Res. 294 provisions related to proxy voting Government shutdown

H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act) S. 527 (Prescription Pricing for the People Act) Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act) S. 527 (Prescription Pricing for the People Act) Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B (Docket No. CMS-2025-1889-0001) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D (Docket No. CMS-2025-1888-0001) Elimination of the Center for Medicare and Medicaid Innovation (CMMI) Approval of reauthorization of Floridas Medicaid hospital-directed payment program (DPP) S. 3315 (Health Care Cybersecurity & Resiliency Act) regarding Sen. Bernie Sanderss amendments to codify Most Favored Nation drug price controls

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses Provisions of H.R. 7148 (Transportation-HUD FY2026 appropriations) related to English-language proficiency standards of commercial truck drivers; priority infrastructure needs, including truck parking project funding; establishing a nationwide dashboard for shippers and carriers to track real-time supply chain movements; cuts or redirecting Infrastructure Investments and Jobs Act funds Nondomiciled holders of Commercial Drivers Licenses, recertification of certain CDL holders Efforts to remove chameleon motor carriers from highways and ensure only legitimate training entities operate commercial drivers license programs H.R. 7539 (Safety and Accountability in Freight Enforcement Act) H.R. 5688 (Non-Domiciled CDL Integrity Act/Dalilahs Law) S. 3950 (SAFER Transport Act)

H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act) S. 527 (Prescription Pricing for the People Act) Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation H.R. 7687 (No Tax on Takings Act)

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B (Docket No. CMS-2025-1889-0001) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D (Docket No. CMS-2025-1888-0001) Elimination of the Center for Medicare and Medicaid Innovation (CMMI) Approval of reauthorization of Floridas Medicaid hospital-directed payment program (DPP) S. 3315 (Health Care Cybersecurity & Resiliency Act) regarding Sen. Bernie Sanderss amendments to codify Most Favored Nation drug price controls

Independent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act) Guidance regarding Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles Phase 3 (GHG3) final rule and the Clean Trucks Plans 2022 Heavy-Duty Nitrous Oxide (NOx) EPAs rescinding the Obama endangerment finding that recategorized greenhouse gases as posing a threat to public health and welfare under the Clean Air Act

H. J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act

H. J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act

H. J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercially successful U.S. patents

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-08607

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercially successful U.S. patents

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and updating of Tax Cuts and Jobs Act (TCJA) tax policy Corporate tax rate

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860 Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care Allowing the Biden-COVID-era Obamacare premium support credits to expire Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-08607

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing Nomination of Robert F. Kennedy Jr. for Health and Human Services secretary

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act)

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution

S. 708/H.R. 1574 (RESTORE Patent Rights Act) Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act Patent Eligibility Restoration Act (PERA) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles Rescinding FMCSAs automatic emergency braking (AEB) systems mandate rule Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors Commercial motor carrier regulatory policy issues, including freight fraud enforcement and Compliance Safety Accountability program Candidates for Federal Motor Carrier Safety Administration leadership positions Nomination of Steve Bradbury for Deputy Secretary of Transportation

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

Independent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

ndependent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

Independent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

Independent contracting in trucking H.R. 20/S. 852 (Protecting the Right to Organize (PRO) Act)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act) Guidance regarding Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles Phase 3 (GHG3) final rule and the Clean Trucks Plans 2022 Heavy-Duty Nitrous Oxide (NOx)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act) Guidance regarding Greenhouse Gas Emissions Standards for Heavy-Duty Vehicles Phase 3 (GHG3) final rule and the Clean Trucks Plans 2022 Heavy-Duty Nitrous Oxide (NOx)

H.R. 346/S. 996 (Preserving Choice in Vehicle Purchases Act) H.R. 2165 (Choice in Automobile Retail Sales (CARS) Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercially successful U.S. patents

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act) H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act)

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

H.R. 1659 (Truck Parking Safety Improvement Act) H.R. 880/S. 337 (Household Goods Shipping Consumer Protection Act) H.R. 2819/S. 1696 (Deregulating Restrictions on Interstate Vehicles and Eighteen-Wheelers (DRIVE) Act) H.R. 2853/S. 1404 (Combating Organized Retail Crime Act) freight fraud provisions Highway Trust Fund fuel tax, vehicle miles traveled Rescinding FMCSAs speed limiter mandate on all heavy-duty commercial motor vehicles (FMCSA-2022-0004-0001) Rescinding FMCSAs automatic emergency braking (AEB) systems mandate Automatic Emergency Braking Test Devices: Heavy Vehicle Automatic Emergency Braking (Docket No. FMCSA-2022-0171) Mitigation of Final Rule, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs (Docket No. DOT-OST-2021-0093-0420) provisions related to specimen collectors USDOT Office of Inspector General freight fraud enforcement, National Consumer Complaint Database (OMB Control Number: 2126-0067) reforms USDOT advisory committees proportion of representatives from small motor carriers Commercial motor carrier regulatory policy issues, including Compliance Safety Accountability program/DataQ Waiver for noncompliant states with National Registry II Implementation with moving from paper to electronic medical certificates Eligibility standards for nondomiciled commercial learners permits and commercial drivers licenses

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act)

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025) Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100) H.R. 791 (Foreign Anti-Digital Piracy Act) S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act) H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA)) H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act) H.R. 861/S. 326 (American Music Fairness Act)